Tia L Bush
CIK 1863418 · Chief Technology & Quality Ofc · last filed 2026-06-24
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
CNTA price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
3RD FLOOR, 1 ASHLEY ROAD, ALTRINCHAM
CHESHIRE, X0 WA14 2DT
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Centessa Pharmaceuticals plc (CNTA) Delisted | Chief Technology & Quality Ofc | 0 | $40.50 | $0 | -$4.64M | 27 | 2026-06-24 |
Holdings By Holder
| Symbol | Holder | Shares | Share of Total | Reported |
|---|---|---|---|---|
| CNTA | Direct | 0 | — | 2026-06-24 |
| By spouse | 0 | — | 2023-05-26 | |
| Total | 0 |
Recent Filings · Page 2 of 4
36 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-09-09 | Centessa Pharmaceuticals plc | Notice (144) Officer · Planned Sep 9, 2025 · 10b5-1 plan Sold: listed on the Sep 10, 2025 notice |
−24,792 | -$495.8K | EDGAR |
| 2025-02-04 | Centessa Pharmaceuticals plc (CNTA) Delisted | Mixed10b5-1 Plan adopted Sep 14, 2024 |
−19,693 | -$332.5K | EDGAR |
| 2025-02-03 | Centessa Pharmaceuticals plc | Notice (144) Officer · Planned Feb 3, 2025 · 10b5-1 plan No sale on file |
−11,000 | -$181.4K | EDGAR |
| 2024-12-31 | Centessa Pharmaceuticals plc (CNTA) Delisted | Tax (F) | −6,419 | -$105.0K | EDGAR |
| 2024-12-17 | Centessa Pharmaceuticals plc | Notice (144) Officer · Planned Dec 17, 2024 · 10b5-1 plan Sold: listed on the Feb 3, 2025 notice |
−17,813 | -$320.6K | EDGAR |
| 2024-12-17 | Centessa Pharmaceuticals plc (CNTA) Delisted | Mixed10b5-1 Plan adopted Sep 14, 2024 |
−9,611 | -$409.3K | EDGAR |
| 2024-12-16 | Centessa Pharmaceuticals plc | Notice (144) Officer · Planned Dec 16, 2024 · 10b5-1 plan Sold: listed on the Dec 17, 2024 notice |
−9,611 | -$159.3K | EDGAR |
| 2024-10-02 | Centessa Pharmaceuticals plc (CNTA) Delisted | Tax (F) | −6,419 | -$101.4K | EDGAR |
| 2024-07-02 | Centessa Pharmaceuticals plc (CNTA) Delisted | Tax (F) | −6,419 | -$58.0K | EDGAR |
| 2024-04-02 | Centessa Pharmaceuticals plc (CNTA) Delisted | Tax (F) | −6,419 | -$72.5K | EDGAR |
10b5-1: the filer ticked the box for trades made under a Rule 10b5-1 trading plan, which sets the sales (or buys) in advance, so they say less about the insider's view at the time than a discretionary trade. The plan's adoption date is shown when the filing's footnotes give it.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment, and an amended or cancelled notice is not listed. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes. Someone who is no longer an officer or director (or never was) files no Form 4, so for them a sale shows up only on a later notice, which lists the seller's sales from the 3 months before it. "No sale on file" means neither record shows one; a dash in Net $ means the value filed on the notice doesn't fit the stock's price (likely a typo).
Sales Reported Only on Form 144
6 sales · $3.40M| Sold | Symbol | Shares | Proceeds | Avg Price | Listed On |
|---|---|---|---|---|---|
| 2025-11-12 | Centessa Pharmaceuticals plc | 40,000 | $1.04M | $26.00 | 2025-11-17 |
| 2025-09-24 | Centessa Pharmaceuticals plc | 35,000 | $840.0K | $24.00 | 2025-11-12 |
| 2025-09-10 | Centessa Pharmaceuticals plc | 25,000 | $550.0K | $22.00 | 2025-09-24 |
| 2025-09-09 | Centessa Pharmaceuticals plc | 24,792 | $495.8K | $20.00 | 2025-09-10 |
| 2024-12-17 | Centessa Pharmaceuticals plc | 17,813 | $320.6K | $18.00 | 2025-02-03 |
| 2024-12-16 | Centessa Pharmaceuticals plc | 9,611 | $157.3K | $16.36 | 2024-12-17 |